Aroa Biosurgery Limited (ARX.AX)
AUD 0.38
(-9.64%)
AUD 0.38
(-9.64%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -9.74 Million AUD | -2529.82% |
| 2023 | -370.68 Thousand AUD | 95.24% |
| 2022 | -7.79 Million AUD | 55.8% |
| 2021 | -17.63 Million AUD | -211.5% |
| 2020 | -5.66 Million AUD | -731.64% |
| 2019 | 896.26 Thousand AUD | 176.03% |
| 2018 | -1.17 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -9.85 Million AUD | -2557.73% |
| 2024 Q2 | -5.83 Million AUD | -100.66% |
| 2024 Q1 | -2.9 Million AUD | -59.41% |
| 2024 Q3 | -2 Million AUD | 65.63% |
| 2024 Q4 | -1.98 Million AUD | 1.09% |
| 2023 Q4 | -1.82 Million AUD | -97.1% |
| 2023 FY | -370.68 Thousand AUD | 95.24% |
| 2023 Q3 | -924.82 Thousand AUD | -233.26% |
| 2023 Q2 | 694.02 Thousand AUD | 0.0% |
| 2022 FY | -7.79 Million AUD | 55.8% |
| 2022 Q4 | -3.11 Million AUD | 0.0% |
| 2022 Q2 | -4.79 Million AUD | 0.0% |
| 2021 FY | -17.63 Million AUD | -211.5% |
| 2021 Q4 | -5.34 Million AUD | 0.0% |
| 2021 Q2 | -12.59 Million AUD | 0.0% |
| 2020 Q2 | -828.97 Thousand AUD | 0.0% |
| 2020 Q4 | -4.84 Million AUD | 0.0% |
| 2020 FY | -5.66 Million AUD | -731.64% |
| 2019 FY | 896.26 Thousand AUD | 176.03% |
| 2018 FY | -1.17 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 72.905% |
| Adherium Limited | -10.22 Million AUD | 4.655% |
| Atomo Diagnostics Limited | -6.84 Million AUD | -42.356% |
| Anteris Technologies Ltd | -67.33 Million AUD | 85.522% |
| Control Bionics Limited | -5.91 Million AUD | -64.84% |
| CardieX Limited | -6.76 Million AUD | -44.091% |
| Compumedics Limited | -338 Thousand AUD | -2784.102% |
| Cochlear Limited | 356.8 Million AUD | 102.732% |
| CleanSpace Holdings Limited | -3.12 Million AUD | -211.731% |
| Cyclopharm Limited | -4.7 Million AUD | -107.374% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -257.13% |
| Nova Eye Medical Limited | -8.79 Million AUD | -10.902% |
| HeraMED Limited | -6.78 Million AUD | -43.702% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 56.915% |
| ImpediMed Limited | -19.79 Million AUD | 50.741% |
| InhaleRx Limited | -1.44 Million AUD | -575.429% |
| LBT Innovations Limited | -3.74 Million AUD | -160.649% |
| Micro-X Limited | -9.76 Million AUD | 0.171% |
| Neurotech International Limited | -5.06 Million AUD | -92.302% |
| OncoSil Medical Limited | -11.91 Million AUD | 18.176% |
| PolyNovo Limited | 5.26 Million AUD | 285.293% |
| Respiri Limited | -7.12 Million AUD | -36.736% |
| SomnoMed Limited | -12.24 Million AUD | 20.369% |
| Universal Biosensors, Inc. | -6.74 Million AUD | -44.599% |
| Uscom Limited | -2.07 Million AUD | -369.853% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | -92.528% |